BriaCell Therapeutics Corp. — Investor Relations & Filings
BriaCell Therapeutics Corp. is a clinical-stage immuno-oncology company developing a novel class of targeted cellular immunotherapies for cancer. Its lead candidate, Bria-IMT™, is a patented, off-the-shelf, cell-based therapy in a pivotal Phase 3 study for advanced metastatic breast cancer. Bria-IMT™, which has received FDA Fast Track designation, is designed to activate the patient's immune system to kill cancer cells. The company is also advancing its next-generation Bria-OTS™ platform, a personalized off-the-shelf immunotherapy that uses HLA matching to provide treatment for a broad patient population. Clinical studies for the Bria-OTS™ platform are ongoing for breast cancer, with planned expansion into prostate cancer, lung cancer, and melanoma.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - BRIACELL THERAPEUTICS CORP. (0001610820) (Filer) | 2026-02-20 | English | |
| DEF 14A Filing | 2026-02-12 | English | |
| SCHEDULE 13G Filing | 2026-01-23 | English | |
| 8-K | 2026-01-15 | English | |
| 424B4 | 2026-01-14 | English | |
| Regulatory Filings 2026 | 2026-01-14 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 32895080 | 8-K - BRIACELL THERAPEUTICS CORP. (0001610820) (Filer) | 2026-02-20 | English | ||
| 30911158 | DEF 14A Filing | 2026-02-12 | English | ||
| 30911060 | SCHEDULE 13G Filing | 2026-01-23 | English | ||
| 12788475 | 8-K | 2026-01-15 | English | ||
| 12788477 | 424B4 | 2026-01-14 | English | ||
| 12788476 | Regulatory Filings 2026 | 2026-01-14 | English | ||
| 12788480 | S-1MEF | 2026-01-14 | English | ||
| 12788478 | Regulatory Filings 2026 | 2026-01-13 | English | ||
| 12788479 | 8-A12B | 2026-01-13 | English | ||
|
2025
6 filings
| |||||
| 12788481 | 8-K | 2025-12-29 | English | ||
| 12788482 | FWP | 2025-12-23 | English | ||
| 12788483 | S-1 | 2025-12-23 | English | ||
| 12788484 | 10-Q | 2025-12-11 | English | ||
| 12788485 | 8-K | 2025-11-29 | English | ||
| 12788486 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
BriaCell Therapeutics Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34987/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34987 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34987 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34987 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34987}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BriaCell Therapeutics Corp. (id: 34987)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.